Publications

Patel T, Zhou J, Piepmeier JM and Saltzman WM: Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Deliv Rev. 2012 May 15;64 (7) :701-5. Epub 2011 Dec 20. PMID: 22210134

Zhou J, Patel TR, Fu M, Bertram JP and Saltzman WM: Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors. Biomaterials. 2012 Jan;33 (2) :583-91. Epub 2011 Oct 19. PMID: 22014944

Zhou J, Atsina KB, Himes BT, Strohbehn GW and Saltzman WM: Novel delivery strategies for glioblastoma. Cancer J. 2012 Jan-Feb;18 (1) :89-99. PMID: 22290262

Zhou J, Liu J, Cheng CJ, Patel TR, Weller CE, Piepmeier JM, Jiang Z and Saltzman WM: Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery. Nat Mater. 2011 Dec 4;11 (1) :82-90. Epub 2011 Dec 4. PMID: 22138789

Olaleye O, Raghunand TR, Bhat S, Chong C, Gu P, Zhou J, Zhang Y, Bishai WR and Liu JO: Characterization of clioquinol and analogues as novel inhibitors of methionine aminopeptidases from Mycobacterium tuberculosis. Tuberculosis (Edinb). 2011 Dec;91 Suppl 1 :S61-5. Epub 2011 Nov 23. PMID: 22115541

Liu J, Jiang Z, Zhou J, Zhang S and Saltzman WM: Enzyme-synthesized poly(amine-co-esters) as nonviral vectors for gene delivery. J Biomed Mater Res A. 2011 Feb;96 (2) :456-65. Epub 2010 Dec 9. PMID: 21171165

Olaleye O, Raghunand TR, Bhat S, He J, Tyagi S, Lamichhane G, Gu P, Zhou J, Zhang Y, Grosset J, Bishai WR and Liu JO: Methionine aminopeptidases from Mycobacterium tuberculosis as novel antimycobacterial targets. Chem Biol. 2010 Jan 29;17 (1) :86-97. PMID: 20142044

Zhou J and Zhang Y: Preclinical development of cancer stem cell drugs. Expert Opin Drug Discov. 2009 Jul;4 (7) :741-52. Epub 2009 Jun 9. PMID: 23489167

Zhou J, Zhang H, Gu P, Margolick JB, Yin D and Zhang Y: Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model. Breast Cancer Res Treat. 2009 May;115 (2) :269-77. Epub 2008 May 28. PMID: 18506619

Zhou J, Zhang H, Gu P, Bai J, Margolick JB and Zhang Y: NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells. Breast Cancer Res Treat. 2008 Oct;111 (3) :419-27. Epub 2007 Oct 27. PMID: 17965935

Tao SC, Li Y, Zhou J, Qian J, Schnaar RL, Zhang Y, Goldstein IJ, Zhu H and Schneck JP: Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers. Glycobiology. 2008 Oct;18 (10) :761-9. Epub 2008 Jul 14. PMID: 18625848

Zhou J and Zhang Y: Cancer stem cells: Models, mechanisms and implications for improved treatment. Cell Cycle. 2008 May 15;7 (10) :1360-70. Epub 2008 Mar 19. PMID: 18418062

Byrne ST, Gu P, Zhou J, Denkin SM, Chong C, Sullivan D, Liu JO and Zhang Y: Pyrrolidine dithiocarbamate and diethyldithiocarbamate are active against growing and nongrowing persister Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2007 Dec;51 (12) :4495-7. Epub 2007 Sep 17. PMID: 17876006

Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J, Margolick JB, Liotta LA, Petricoin E 3rd and Zhang Y: Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A. 2007 Oct 9;104 (41) :16158-63. Epub 2007 Oct 2. PMID: 17911267

Yin X, Zhou J, Jie C, Xing D and Zhang Y: Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sci. 2004 Sep 17;75 (18) :2233-44. PMID: 15325848

Zhang H, Wang Z and Zhou J: Cytoplasm prepared from all-trans retinoic acid (ATRA)-treated human hematopoietic progenitor cells induces differentiation of both ATRA sensitive and ATRA resistant leukemia cells. Biol Pharm Bull. 2004 Apr;27 (4) :570-3. PMID: 15056869